Clearance came after an investigational device exemption study of 135 patients in four countries, including the U.S.
The Pod aims to be an improved vertebral fracture repair device.
More Articles on Devices:
K2M Spinal Deformity Device Implanted in First French Hospital Procedure
Vivex Biomedical Raises $7.4M for Stem Cell, Implant Technologies
Alphatec Holdings to Reduce Workforce, Operating Expenses for French Affiliate
